A citation-based method for searching scientific literature

Su-Jin Kim, Cuilan Nian, Doris J Doudet, Christopher H S McIntosh. Diabetes 2009
Times Cited: 76



Kei Ohnuma, Masahiko Uchiyama, Tadanori Yamochi, Kunika Nishibashi, Osamu Hosono, Nozomu Takahashi, Shinichiro Kina, Hirotoshi Tanaka, Xin Lin, Nam H Dang, Chikao Morimoto. J Biol Chem 2007
Times Cited: 84




List of shared articles



Times cited

Dipeptidyl peptidase-4 (DPP4) inhibitor sitagliptin alleviates liver inflammation of diabetic mice by acting as a ROS scavenger and inhibiting the NFκB pathway.
Xin Wang, Jing Ke, Ying-Jun Zhu, Bin Cao, Rui-Li Yin, Yan Wang, Ling-Ling Wei, Li-Jie Zhang, Long-Yan Yang, Dong Zhao. Cell Death Discov 2021
0

Dipeptidyl peptidase in autoimmune pathophysiology.
Kei Ohnuma, Osamu Hosono, Nam H Dang, Chikao Morimoto. Adv Clin Chem 2011
50


Combination of vitamin D and dipeptidyl peptidase-4 inhibitors (VIDPP-4i) as an immunomodulation therapy for autoimmune diabetes.
Marcelo Maia Pinheiro, Felipe Moura Maia Pinheiro, Susana Nogueira Diniz, Andrea Fabbri, Marco Infante. Int Immunopharmacol 2021
1

DPP-4 Inhibition Leads to Decreased Pancreatic Inflammatory Profile and Increased Frequency of Regulatory T Cells in Experimental Type 1 Diabetes.
Mariana Rodrigues Davanso, Carolina Caliari-Oliveira, Carlos Eduardo Barra Couri, Dimas Tadeu Covas, Angela Merice de Oliveira Leal, Júlio César Voltarelli, Kelen Cristina Ribeiro Malmegrim, Juliana Navarro Ueda Yaochite. Inflammation 2019
6

Dipeptidyl peptidase 4 inhibitors and their potential immune modulatory functions.
Shiying Shao, QinQin Xu, Xuefeng Yu, Ruping Pan, Yong Chen. Pharmacol Ther 2020
38